Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis speeds up Tasigna programme

July 25, 2006
Sales and Marketing

Novartis' new cancer drug will be submitted earlier than expected for European and US approval after showing positive results in …

News

Are you ready to become an interim manager?

July 25, 2006
Business Services interim management, recruitment

The last few years have seen both dramatic and rapid changes in the adoption of interim management in the life …

Feature

Use your intelligence to watch the competition

July 25, 2006
Research and Development, Sales and Marketing market research

One of the reasons the executives of ill-fated US energy group Enron were for a while 'the smartest guys in …

Feature

NHS allergy services criticised

July 21, 2006

People with allergies often feel let down by NHS services with patient groups expected to make up shortfalls, according to …

News

Roche surges on cancer drug sales

July 21, 2006
Sales and Marketing

Strong demand for Roche's cancer portfolio helped the Swiss pharma company grow at more than three times the industry rate …

News

Patient dies after winning access to cancer drug

July 21, 2006

A Lancashire man with terminal lung cancer has died just days after winning a court battle to force his PCT …

News

Pfizer sets out on $17 billion acquisition trail

July 21, 2006
Sales and Marketing Pfizer

Pfizer, the world's biggest pharmaceutical company, has earmarked $17 billion to spend on new products and technologies over the next …

News

UK uptake of vaccine boosts Wyeth

July 21, 2006
Sales and Marketing

The long-awaited addition of Wyeth Prevnar to the UK's vaccination programme has helped the company increase revenues in the second …

News

Xeloda filed for advanced stomach cancer

July 21, 2006
Sales and Marketing

Roche has filed its drug Xeloda to treat patients with advanced stomach cancer, the second biggest cancer killer worldwide.The oral …

News

New licence allows patients to switch to Arimidex

July 14, 2006
Sales and Marketing

AstraZeneca has gained a new licence for its breast cancer drug Arimidex to allow patients to switch from tamoxifen after …

News

Tysabri returns with new safety precautions

July 13, 2006
Sales and Marketing

Multiple sclerosis drug Tysabri is set to be re-launched after overcoming serious concerns about its safety.Co-marketed by Elan and Biogen …

News

AstraZeneca and Abbott to develop combined lipid-targeting drug

July 13, 2006
Sales and Marketing

AstraZeneca and Abbott are to co-develop and market a combination treatment that will target three important blood lipids in one …

News

PCT fights Herceptin approval

July 12, 2006

A primary care trust has appealed against the NICE recommendation of Herceptin, apparently challenging how many women should receive the …

News

MabThera approved for rheumatoid arthritis

July 11, 2006
Sales and Marketing

Roche's blockbuster cancer drug MabThera has gained European marketing approval to treat rheumatoid arthritis.First launched in 1997, MabThera (rituximab) made …

News

Avastin filed for breast cancer treatment

July 10, 2006
Sales and Marketing

Roche's Avastin could be licensed to treat advanced breast cancer in Europe by early 2007, following its filing with regulator …

News

Lilly to close UK manufacturing site but retains R&D operations

July 7, 2006
Manufacturing and Production

Pharmaceutical company Lilly is to close its UK manufacturing facility in Basingstoke with as many as 300 employees expected to …

News

Anti-smoking ad lights up Best of Health awards

July 7, 2006
Medical Communications Best of Health, advertising, awards, events

Clear Marketing Communications has taken the top prize at the 2006 Best of Health Awards with a striking advert highlighting …

Feature

Work progressing on Scotland’s ‘unique’ biotech campus

July 7, 2006
Research and Development

Plans to make Scotland a major centre for innovative biotech and pharmaceutical research are progressing, with a major new centre …

News

Company behind Northwick Park trial files for insolvency

July 7, 2006
Sales and Marketing

The pharmaceutical company behind TGN 1412, the drug which caused near-fatal reactions in six clinical trials volunteers at Northwick Park, …

News

Practice-based commissioning uptake exaggerated, say GPs

July 7, 2006

Doctors' leaders have challenged claims by the government that as many as 40% of GPs are engaged in practice-based commissioning, …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026